71 related articles for article (PubMed ID: 26357005)
1. ETV/Pea3 family transcription factor-encoding genes are overexpressed in CIC-mutant oligodendrogliomas.
Padul V; Epari S; Moiyadi A; Shetty P; Shirsat NV
Genes Chromosomes Cancer; 2015 Dec; 54(12):725-33. PubMed ID: 26357005
[TBL] [Abstract][Full Text] [Related]
2. Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy.
Sasaki H; Kitamura Y; Toda M; Hirose Y; Yoshida K
Brain Tumor Pathol; 2024 Apr; 41(2):43-49. PubMed ID: 38564040
[TBL] [Abstract][Full Text] [Related]
3. CIC is a critical regulator of neuronal differentiation.
Hwang I; Pan H; Yao J; Elemento O; Zheng H; Paik J
JCI Insight; 2020 May; 5(9):. PubMed ID: 32229723
[TBL] [Abstract][Full Text] [Related]
4. Perfusion percentage signal recovery and a mundane chicken wire: what could they have to do in oligodendrogliomas?
Lui E
Eur Radiol; 2024 Mar; ():. PubMed ID: 38530428
[No Abstract] [Full Text] [Related]
5. Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1.
Cahill DP; Louis DN; Cairncross JG
CNS Oncol; 2015; 4(5):287-94. PubMed ID: 26545048
[TBL] [Abstract][Full Text] [Related]
6. Multi-Omic Analysis of CIC's Functional Networks Reveals Novel Interaction Partners and a Potential Role in Mitotic Fidelity.
Takemon Y; LeBlanc VG; Song J; Chan SY; Lee SD; Trinh DL; Ahmad ST; Brothers WR; Corbett RD; Gagliardi A; Moradian A; Cairncross JG; Yip S; Aparicio SAJR; Chan JA; Hughes CS; Morin GB; Gorski SM; Chittaranjan S; Marra MA
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345142
[No Abstract] [Full Text] [Related]
7. E26 transformation-specific transcription variant 5 in development and cancer: modification, regulation and function.
Wei Y; Han S; Wen J; Liao J; Liang J; Yu J; Chen X; Xiang S; Huang Z; Zhang B
J Biomed Sci; 2023 Mar; 30(1):17. PubMed ID: 36872348
[TBL] [Abstract][Full Text] [Related]
8. Preclinical Models of Low-Grade Gliomas.
Dasgupta P; Balasubramanyian V; de Groot JF; Majd NK
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765553
[TBL] [Abstract][Full Text] [Related]
9. CIC reduces xCT/SLC7A11 expression and glutamate release in glioma.
Park JW; Kilic O; Deo M; Jimenez-Cowell K; Demirdizen E; Kim H; Turcan Ş
Acta Neuropathol Commun; 2023 Jan; 11(1):13. PubMed ID: 36647117
[TBL] [Abstract][Full Text] [Related]
10. Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel.
Higa N; Akahane T; Yokoyama S; Yonezawa H; Uchida H; Fujio S; Kirishima M; Takigawa K; Hata N; Toh K; Yamamoto J; Hanaya R; Tanimoto A; Yoshimoto K
Neurol Med Chir (Tokyo); 2022 Sep; 62(9):391-399. PubMed ID: 36031351
[TBL] [Abstract][Full Text] [Related]
11. ETS factors in prostate cancer.
Qian C; Li D; Chen Y
Cancer Lett; 2022 Apr; 530():181-189. PubMed ID: 35033589
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of ETV4 promotes autophagy-dependent apoptosis in GBM cells by reducing the transcriptional activation of EMP1.
Wang J; Sun C; Li J; Jiang H; Qiu Y; Gong M
Oncol Lett; 2022 Feb; 23(2):41. PubMed ID: 34976153
[TBL] [Abstract][Full Text] [Related]
13. Current Advances and Challenges in Radiomics of Brain Tumors.
Yi Z; Long L; Zeng Y; Liu Z
Front Oncol; 2021; 11():732196. PubMed ID: 34722274
[TBL] [Abstract][Full Text] [Related]
14. The role of human endogenous retroviruses in gliomas: from etiological perspectives and therapeutic implications.
Shah AH; Gilbert M; Ivan ME; Komotar RJ; Heiss J; Nath A
Neuro Oncol; 2021 Oct; 23(10):1647-1655. PubMed ID: 34120190
[TBL] [Abstract][Full Text] [Related]
15. ETV4 and ETV5 drive synovial sarcoma through cell cycle and DUX4 embryonic pathway control.
DeSalvo J; Ban Y; Li L; Sun X; Jiang Z; Kerr DA; Khanlari M; Boulina M; Capecchi MR; Partanen JM; Chen L; Kondo T; Ornitz DM; Trent JC; Eid JE
J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 33983905
[TBL] [Abstract][Full Text] [Related]
16. Gene Regulatory Network of ETS Domain Transcription Factors in Different Stages of Glioma.
Babal YK; Kandemir B; Kurnaz IA
J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33671331
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Utility of Oncomine Comprehensive Assay v3 in Differentiating Between Isocitrate Dehydrogenase (IDH)-mutated Grade II-III Astrocytoma and Oligodendroglioma.
Kim SW; Park BJ; Kim HS; Na K
In Vivo; 2021; 35(2):921-927. PubMed ID: 33622884
[TBL] [Abstract][Full Text] [Related]
18. TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L.
Wong D; Sogerer L; Lee SS; Wong V; Lum A; Levine AB; Marra MA; Yip S
BMC Biol; 2020 Oct; 18(1):154. PubMed ID: 33115448
[TBL] [Abstract][Full Text] [Related]
19. Capicua in Human Cancer.
Kim JW; Ponce RK; Okimoto RA
Trends Cancer; 2021 Jan; 7(1):77-86. PubMed ID: 32978089
[TBL] [Abstract][Full Text] [Related]
20. Radiomics Features Predict CIC Mutation Status in Lower Grade Glioma.
Zhang L; Giuste F; Vizcarra JC; Li X; Gutman D
Front Oncol; 2020; 10():937. PubMed ID: 32676453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
